Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: A review

Journal of Reconstructive Microsurgery

Volumn 27, Issue 1, 2011, Pages 67-73

  Hui Chou, Helen G ^a   Hashemi, Sharyhar S ^b   Hoke, Ahmet ^c   Dellon, A Lee ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Dellon Institute for Peripheral Nerve Surgery   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Charcot Marie Tooth disease; hereditary neuropathy with liability to pressure palsies; neurolysis; Peripheral myelin protein 22

Indexed keywords

PERIPHERAL MYELIN PROTEIN 22;

CHROMOSOME 17P; CHROMOSOME DUPLICATION; CONGENITAL HYPOMYELINATING NEUROPATHY; ELECTROMYOGRAPHY; GENE DELETION; GENE EXPRESSION; GENETIC DISORDER; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NERVE BIOPSY; NERVE COMPRESSION; NERVE FIBER; NERVE REGENERATION; NEUROPATHY; PARESTHESIA; PERIPHERAL NEUROPATHY; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURAL NERVE; TREATMENT CONTRAINDICATION; WEAKNESS;

ARTHROGRYPOSIS; CHARCOT-MARIE-TOOTH DISEASE; DISEASE PROGRESSION; ELECTROMYOGRAPHY; GENE EXPRESSION; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MICROSURGERY; MYELIN PROTEINS; PHENOTYPE; POINT MUTATION;

EID: 78650783207     PISSN: 0743684X     EISSN: 10988947     Source Type: Journal    
DOI: 10.1055/s-0030-1267832     Document Type: Review

References (54)

1. Snipes G J., Suter U, Welcher A A., Shooter E M. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992 117 225-238
2. Suter U, Welcher A A., Snipes G J. Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system. Trends Neurosci 1993 16 50-56
3. Taylor V, Welcher A A., Program A E., Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem 1995 270 28824-28833
4. Suter U, Scherer S S. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003 4 714-726
5. Pareek S, Suter U, Snipes G J., Welcher A A., Shooter E M., Murphy R A. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 1993 268 10372-10379
6. Patel P I., Roa B B., Welcher A A. et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992 1 159-165
7. Ohsawa Y, Murakami T, Miyazaki Y, Shirabe T, Sunada Y. Peripheral myelin protein 22 is expressed in human central nervous system. J Neurol Sci 2006 247 11-15
8. Parmantier E, Cabon F, Braun C, D'Urso D, Müller H W., Zalc B. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 1995 7 1080-1088
9. Sanahuja J, Franco E, Rojas-García R et al. Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association. Arch Neurol 2005 62 1911-1914
10. Tackenberg B, Möller J C., Rindock H et al. CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology 2006 67 2250-2252
11. Amato A A., Barohn R J. Hereditary neuropathy with liability to pressure palsies: association with central nervous system demyelination. Muscle Nerve 1996 19 770-773
12. Dackovi J, Rakocevi-Stojanovi V, Pavlovi S et al. Hereditary neuropathy with liability to pressure palsies associated with central nervous system myelin lesions. Eur J Neurol 2001 8 689-692
13. Schneider C, Reiners K, Friedl W, Ebner R, Toyka K V. Involvement of the visual pathway in hereditary neuropathy with liability to pressure palsies. J Neurol 2000 247 222-223
14. Naef R, Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech 1998 41 359-371
15. Stögbauer F, Young P, Kuhlenbäumer G, De Jonghe P, Timmerman V. Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 2000 54 546-551
16. Patel P I., Lupski J R. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 1994 10 128-133
17. Nicholson G A., Valentijn L J., Cherryson A K. et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994 6 263-266
18. Hodapp J A., Carter G T., Lipe H P., Michelson S J., Kraft G H., Bird T D. Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes. Arch Neurol 2006 63 112-117
19. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller H W. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 1995 14 1122-1128
20. Fabbretti E, Edomi P, Brancolini C, Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 1995 9 1846-1856
21. Vallat J M., Sindou P, Preux P M. et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996 39 813-817
22. Sahenk Z, Chen L, Freimer M. A novel PMP22 point mutation causing HNPP phenotype: studies on nerve xenografts. Neurology 1998 51 702-707
23. Shaffer L G., Kennedy G M., Spikes A S., Lupski J R. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet 1997 69 325-331
24. Chance P F., Abbas N, Lensch M W. et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994 3 223-228
25. Sahenk Z, Chen L, Mendell J R. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999 45 16-24
26. Lupski J R. An inherited DNA rearrangement and gene dosage effect are responsible for the most common autosomal dominant peripheral neuropathy: Charcot-Marie-Tooth disease type 1A. Clin Res 1992 40 645-652
27. Lupski J R. Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity. Pediatr Res 1999 45 159-165
28. Gochard A, Guennoc A M., Praline J, Malinge M C., de Toffol B, Corcia P. Bilateral hand amyotrophy with PMP-22 gene deletion. Eur J Neurol 2007 14 115-116
29. Roa B B., Garcia C A., Suter U et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993 329 96-101 (Pubitemid 23188823)
30. Li J, Ghandour K, Radovanovic D et al. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. Arch Neurol 2007 64 974-978
31. Rautenstrauss B, Fuchs C, Liehr T, Grehl H, Murakami T, Lupski J R. Visualization of the CMT1A duplication and HNPP deletion by FISH on stretched chromosome fibers. J Peripher Nerv Syst 1997 2 319-322
32. Gouider R, LeGuern E, Gugenheim M et al. Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology 1995 45 2018-2023
33. Mariman E C., Gabreëls-Festen A A., van Beersum S E. et al. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994 36 650-655
34. Hanemann C O., D'Urso D, Gabreëls-Festen A A., Müller H W. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A. Brain 2000 123 Pt 5 1001-1006
35. Mouton P, Tardieu S, Gouider R et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999 52 1440-1446
36. Reilly M M. Sorting out the inherited neuropathies. Pract Neurol 2007 7 93-105
37. Celik Y, Kilinçer C, Hamamciolu M K. et al. Hereditary neuropathy with liability to pressure palsies in a Turkish patient (HNPP): a rare cause of entrapment neuropathies in young adults. Turk Neurosurg 2008 18 82-84
38. Farooq M U., Martin J H., Andary M T. Unusual presentation of hereditary neuropathy with liability to pressure palsies. J Brachial Plex Peripher Nerve Inj 2008 3 2
39. Li J, Bai Y, Ghandour K et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 2005 128 (Pt 5) 1168-1177
40. Guyton G P. Current concepts review: orthopaedic aspects of Charcot-Marie-Tooth disease. Foot Ankle Int 2006 27 1003-1010
41. Timmerman V, Nelis E, Van Hul W et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992 1 171-175
42. Hanemann C O., Müller H W. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy. Trends Neurosci 1998 21 282-286
43. Hanemann C O., Stoll G, D'Urso D et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994 37 654-659
44. Sambuughin N, de Bantel A, McWilliams S, Sivakumar K. Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene. Neurology 2003 60 506-508
45. Padua L, Aprile I, Cavallaro T et al, Italian CMT QoL Study Group. Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study. Neurol Sci 2008 29 157-162
46. Padua L, Cavallaro T, Pareyson D, Quattrone A, Vita G, Schenone A, Italian CMT QoL Study Group. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci 2008 29 193-194
47. Padua L, Shy M E., Aprile I et al. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst 2008 13 64-70
48. Nishimura T, Yoshikawa H, Fujimura H, Sakoda S, Yanagihara T. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol 1996 92 454-460
49. Hayasaka K, Himoro M, Sawaishi Y et al. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 1993 5 266-268
50. Ikegami T, Ikeda H, Aoyama M et al. Novel mutations of the peripheral myelin protein 22 gene in two pedigrees with Dejerine-Sottas disease. Hum Genet 1998 102 294-298
51. Ikegami T, Nicholson G, Ikeda H et al. A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 1996 222 107-110
52. Ikegami T, Nicholson G, Ikeda H et al. De novo mutation of the myelin Po gene in Déjérine-Sottas disease (hereditary motor and sensory neuropathy type III): two amino acid insertion after Asp 118. Hum Mutat 1998 S103-S105
53. Roa B B., Dyck P J., Marks H G., Chance P F., Lupski J R. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993 5 269-273
54. Chandra S R., Kalpana D, Radhakrishnan V V., Kannan S R. Congenital hypomyelinating neuropathy. Indian Pediatr 2003 40 1084-1087